Profiling drug candidates
for liver disease
Generating pre-clinical human data for therapeutic candidates with in-vitro liver and metabolic disease models.
Enabling cures for liver disease through highly predictive in vitro modeling
We generate high-quality, phenotypically relevant disease modeled hepatocytes that can be utilized to screen compounds.
Combine our expertise at generating iPSC-derived hepatocyte disease models with our wide panel of bespoke bioassays. We work as partners with your team to design and implement in-house screening of small molecules and advanced genetic therapies, so you can advance your program at speed.
DefiniGEN has a large panel of iPSC lines allowing us to offer all our disease models and cell-based bioassays in donors ranging in gender, age and ethnicity. Researchers use our donor panels to further screen their lead candidates and potentially inform the stratification of a successful clinical trial.